NCCN Guidelines® Insights: Testicular Cancer, Version 2.2025

The NCCN Guidelines for Testicular Cancer provide recommendations for the multidisciplinary approach to the diagnostic workup, treatment, and follow-up for testicular germ cell tumors, including both seminoma and nonseminoma. These NCCN Guidelines Insights discuss the current treatment recommendations and supporting clinical data for seminomas as presented in Version 2.2025 of the NCCN Guidelines for Testicular Cancer.

Authors

Institutions

Publication Details

Journal
Journal of the National Comprehensive Cancer Network
Published
2025-04-01
DOI
https://doi.org/10.6004/jnccn.2025.0018
Citations
14
Primary Topic
Testicular diseases and treatments
Type
article
Field-Weighted Citation Impact
28.09

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

NCCN Guidelines® Insights: Testicular Cancer, Version 2.2025

Laura Graham, Benjamin Louis Maughan, Hamid Emamekhoo, Jean‐Claude M. Rwigema et al.
14 citations
Journal of the National Comprehensive Cancer Network
Testicular diseases and treatments
28.09
article

NCCN Guidelines® Insights: Testicular Cancer, Version 2.2025

Laura Graham, Benjamin Louis Maughan, Hamid Emamekhoo, Jean‐Claude M. Rwigema, Timothy D. Gilligan, Ankeet Shah, Phillip M. Pierorazio, Daniel M. Geynisman, Joel Picus, Harshraj Leuva, Paul Monk, Kanishka Sircar, Bailee Sliker, Alexandra Drakaki, Soroush Rais‐Bahrami, Nabil Adra, Thenappan Chandrasekar, Scott E. Eggener, Nirmish Singla, Kosj Yamoah, Bradley A. McGregor, Philip J. Saylor, Peter A. Humphrey, Sarah Montgomery, Aditya Bagrodia, Daniel Wei Lin, Daniel N. Costa, David James VanderWeele, Amy N. Luckenbaugh, Rahul Aggarwal, Ali Zhumkhawala, Zachery R. Reichert, Darren R. Feldman, Sumit Shah, Ellis G. Levine
article en
14 citations

Abstract

The NCCN Guidelines for Testicular Cancer provide recommendations for the multidisciplinary approach to the diagnostic workup, treatment, and follow-up for testicular germ cell tumors, including both seminoma and nonseminoma. These NCCN Guidelines Insights discuss the current treatment recommendations and supporting clinical data for seminomas as presented in Version 2.2025 of the NCCN Guidelines for Testicular Cancer.

Journal of the National Comprehensive Cancer NetworkVol. 23(4)
Fox Chase Cancer Center (US), Roswell Park Comprehensive Cancer Center (US), Barnes-Jewish Hospital (US), City Of Hope National Medical Center (US), Cleveland Clinic (US), Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa (ZA), Memorial Sloan Kettering Cancer Center (US), The University of Texas MD Anderson Cancer Center (US), Breast Cancer Research Foundation (US), University of Utah (US), The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (US), UC San Diego Health System (US), Huntsman Cancer Institute (US), Cancer Institute (WIA) (IN), Susan Thompson Buffett Foundation (US), WinnMed (US), Yale Cancer Center (US), Moffitt Cancer Center (US), Massachusetts General Hospital (US), Fred Hutch Cancer Center (US), Southwestern Medical Center (US), Jewish Hospital (US), University of Wisconsin Carbone Cancer Center (US), Sidney Kimmel Cancer Center (US), University Hospitals Seidman Cancer Center (US), Duke Medical Center (US), University of Colorado Cancer Center (US), Dana-Farber Brigham Cancer Center (US), Smilow Cancer Hospital (US), UCSF Helen Diller Family Comprehensive Cancer Center (US), Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Indiana University Melvin and Bren Simon Comprehensive Cancer Center, Moores Cancer Center, University of Chicago Medicine Comprehensive Cancer Center, UCLA Jonsson Comprehensive Cancer Center, Vanderbilt-Ingram Cancer Center, Stanford Cancer Institute, Duke Cancer Institute, Fred and Pamela Buffett Cancer Center, UC Davis Comprehensive Cancer Center, Harold C. Simmons Comprehensive Cancer Center, O'Neal Comprehensive Cancer Center, National Comprehensive Cancer Network, Indiana University (US), University of Pennsylvania (US), University of California, Davis (US), The University of Texas Southwestern Medical Center (US), University of Colorado Denver (US)
AstraZeneca, National Comprehensive Cancer Network, Janssen Scientific Affairs, Springworks Therapeutics, Coherus Biosciences, Janssen Biotech
Good health and well-being
Openalex Percentile: Top 0%
Testicular diseases and treatments
28.09
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.